Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis
- 25 March 2010
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 52 (2), 199-202
- https://doi.org/10.1111/j.1442-200x.2009.02941.x
Abstract
Background: The objective of this study was to determine the efficacy and safety of nebulized 3% hypertonic saline solution and salbutamol in the treatment of mild to moderate bronchiolitis. Methods: In a randomized controlled trial, 93 infants with mild to moderate bronchiolitis were divided into two groups. The infants received inhalation of 2.5 mg (0.5 mL) salbutamol dissolved in either 4.0 mL normal (0.9%) saline (control group, n= 43) or 4.0 mL hypertonic (3%) saline (treatment group, n= 50). The therapy was repeated three times daily until discharge. Cough, wheezing, pulmonary physical signs, and the length of hospital stay were recorded. Results: Wheezing remission time was 3.8 ± 1.1 days in the control group and 2.7 ± 0.9 days in the treatment group (P < 0.01). Cough remission time was 6.3 ± 0.9 days in the control group and 5.3 ± 0.8 days in the treatment group (P < 0.01). The moist crackles disappeared at 5.4 ± 0.8 days in the treatment group versus 6.2 ± 0.9 days in the control group (P < 0.01). Furthermore, the average length of hospital stay decreased from 7.4 ± 1.5 days in the control group to 6.0 ± 1.2 days in the treatment group (P < 0.01). No obvious adverse effects were observed. Conclusions: Inhalation of nebulized 3% hypertonic saline solution and salbutamol is a safe and effective therapy for patients with mild to moderate bronchiolitis.Keywords
This publication has 20 references indexed in Scilit:
- Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in InfantsThe Journal of Pediatrics, 2007
- Direct Medical Costs of Bronchiolitis Hospitalizations in the United StatesPEDIATRICS, 2006
- Diagnosis and Management of BronchiolitisPEDIATRICS, 2006
- Bronchiolitis, respiratory syncytial virus, and recurrent wheezing: what is the relationship?Revista Do Hospital Das Clinicas, 2003
- Respiratory Syncytial Virus and Parainfluenza VirusThe New England Journal of Medicine, 2001
- The pharmacologic mechanism by which inhaled epinephrine reduces airwaX obstruction in respiratory syncytial virus—associated bronchiolitisThe Journal of Pediatrics, 2000
- Clinical Study and Literature Review of Nasal IrrigationThe Laryngoscope, 2000
- Inhaled hypertonic saline increases sputum expectoration in cystic fibrosisJournal of Paediatrics and Child Health, 1996
- Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitroPediatric Pulmonology, 1995
- BronchiolitisPediatrics in Review, 1993